Zenodo
NAD+ Precursor Nicotinamide Riboside with Thiamine Combination Therapy
Preprint: commentaryInterventions
Abstract
Nicotinamide riboside increases NAD+/NADH ratio to drive residual OGDH complex activity, while high-dose thiamine enhances thiamine diphosphate cofactor availability for pyruvate dehydrogenase and α-ketoglutarate dehydrogenase complexes
The paper
MedicOath
Zenodo, 28 Apr 2026, Open access, CC0, Preprint, not peer-reviewed


